Refine by
Molecular Diagnostic Equipment Supplied In Usa Texas
8 equipment items found
by:Diasorin based inSALUGGIA, ITALY
The VERIGENE® II System is a sample-to-answer molecular diagnostic platform capable of performing both targeted and multiplex testing on a single sample. The system is fully-integrated and performs extraction, amplification, hybridization, and detection—all in one cartridge. Its proprietary Flex® Software enables users to test and pay only for the ...
Premium
Manufactured by:Bertin Technologies based inMontigny-le-Bretonneux, FRANCE
BEC SARS-CoV-2 RT-LAMP system is designed for the rapid detection of SARS-CoV-2 genome on the field, in less than 30 ...
by:Diasorin based inSALUGGIA, ITALY
Focus Diagnostics’ Simplexa™ Adenovirus Molecular Control consists of inactivated adenovirus intended to be used as a control in molecular testing. This control is not intended for use with donor screening tests. ...
by:Diasorin based inSALUGGIA, ITALY
Focus Diagnostics’ Simplexa™ BKV Molecular Control consists of a DNA fragment to a well conserved region of BKV VP2 gene intended to be used as a control in molecular testing. This control is not intended for use as a control with screening tests for the presence of BKV in blood or blood products. ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling more informed choices about treatment and follow-up ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. However, within five years, approximately 30% of patients will develop metastasis – rising to nearly 50% in the following ...
Manufactured by:BioGX, Inc. based inBirmingham, ALABAMA (USA)
The test is offered in BioGX’s trusted, easy to use Sample-Ready™ format where all required reagents for real-time PCR are lyophilized in a single tube. BioGX provided tube snaps into a test-specific position on the BD MAX™ total nucleic acid extraction cartridge enabling Sample-to-Answer molecular testing. BioGX kits can be shipped anywhere in the world with no refrigeration ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Recurrence or Metastasis: DecisionDx-Melanoma was designed to address the need for a more accurate predictor of metastatic risk in patients diagnosed with cutaneous (skin) melanoma. ...